Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
45.1M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
8.47M
-
Shares change
-
-213K
-
Total reported value, excl. options
-
$222M
-
Value change
-
-$3.28M
-
Number of buys
-
17
-
Number of sells
-
-18
-
Price
-
$26.21
Significant Holders of Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share (YMAB) as of Q1 2019
47 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share as of Q1 2019.
Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share (YMAB) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.47M shares
of 45.1M outstanding shares and own 18.78% of the company stock.
Largest 10 shareholders include Sofinnova Investments, Inc. (2.1M shares), FMR LLC (1.63M shares), SCOPIA CAPITAL MANAGEMENT LP (920K shares), Cormorant Asset Management, LP (715K shares), ALLIANCEBERNSTEIN L.P. (664K shares), PRICE T ROWE ASSOCIATES INC /MD/ (640K shares), BlackRock Inc. (369K shares), MILLENNIUM MANAGEMENT LLC (286K shares), VANGUARD GROUP INC (285K shares), and GOLDMAN SACHS GROUP INC (225K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.